Etoposide (VP-16) as first-line, single agent chemotherapeutic drug in low-risk gestational trophoblastic disease

International Journal of Gynecological Cancer

Volumn 7, Issue 5, 1997, Pages 400-404

  Matsui, H ^a   Iitsuka, Y ^a   Seki, K ^a   Sekiya, S ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Etoposide (VP 16); Gestational trophoblastic disease

Indexed keywords

ETOPOSIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RESISTANCE; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR;

EID: 0030699194     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.00036.x     Document Type: Article

References (19)

1. Li MC, Hertz R, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Biol Med 1956; 93: 361-366.
2. Hammond CB, Hertz R, Ross GT. Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms. Am J Obstet Gynecol 1967; 98: 71-78.
3. Ross GT, Stolbach LL, Hertz R. Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. Cancer Res 1962; 22: 1015-1017.
4. Berkowitz RS, Goldstein DP, Bernstein MR. Ten year's experience with methotrexate and folic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986; 23: 111-118.
5. Bagshawe KD, Dent J, Newlands ES, Begent RHJ, Rustin GJS. The role of low-dose methotrexate and folic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 1989; 96: 795-802.
6. Homesley HD, Blessing JA, Schlaerth JB, Rettenmaier M, Major FJ. Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: A gynecologic oncology group study. Gynecol Oncol 1990; 39: 305-308.
7. Schlaerth JB, Morrow CP, Nalick RH, Gaddis G, Jr. Single-dose actinomycin D in the treatment of postmolar trophoblastic disease. Gynecol Oncol 1984; 19: 53-56.
8. Newlands ES, Bagshawe KD. Anti-tumor activity of the epipodophyllin derivative VP16-213 (Etoposide: NSC-141540) in gestational choriocarcinoma. Eur J Cancer 1979; 16: 401-405.
9. Hammond CB, Borchert LG, Tyrey L, Creasman WT, Parker RT. Treatment of metastatic trophoblastic disease: Good and poor prognosis. Am J Obstet Gynecol 1973; 115: 451-457.
10. Lurain JR, Elfstrand EP. Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol 1995; 172: 574-579.
11. Wong LC, Choo YC, Ma HK. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 1985; 152: 59-62.
12. Hoffman MS, Fiorica JV, Gleeson NC, Roberts WS, Cavanagh D. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Gynecol Oncol 1996; 60: 292-294.
13. Elit L, Covens A, Osborne R, Gerulath A, Murphy J, Rosen B, Sturgeon J. High-dose methotrexate for gestational trophoblastic disease. Gynecol Oncol 1994; 54: 282-287.
14. Wong LC, Choo YC, Ma HK. Primary oral etoposide therapy in gestational trophoblastic disease: An update. Cancer 1986; 58: 14-17.
15. Hitchins RN, Holden L, Newlands ES, Begent RHJ, Rustin GJS, Bagshawe KD. Single agent etoposide in gestational trophoblastic tumours: Experience at Charing Cross Hospital 1978-1987. Eur J Cancer Clin Oncol 1988; 24: 1041-1046.
16. Mangili G, Garavaglia E, Frigerio L, Candotti G, Ferrari A. Management of low-risk gestational trophoblastic tumors with etoposide (VP16) in patients resistant to methotrexate. Gynecol Oncol 1996; 61: 218-220.
17. Roberts JP, Lurain JR. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996; 174: 1917-1924.
18. Soper JT, Clarke-Pearson DL, Berchuck A, Rodriguez G, Hammond CB. Five-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 1994; 54: 76-79.
19. Matsui H, Seki K, Sekiya S, Takamizawa H. Reproductive status of patients with gestational trophoblastic disease treated with etoposide. J Reprod Med 1997; 42: 104-110.